BOT 9.23% 35.5¢ botanix pharmaceuticals ltd

The dermatology thing was really pushed forward by Matt and...

  1. 482 Posts.
    lightbulb Created with Sketch. 609
    The dermatology thing was really pushed forward by Matt and things have not worked out how we would all have liked. The design of the acne phase 2 stuffed up the US trials and questions can be asked about the phase 1 dermatitis trials given the phase 2 results.

    IMO Matt is a get it up and running kinda guy who then passes the torch to others to make the most of commercialisation opportunities. Enter Vince, our $5 billion dollar man. From what I can gather Vince has serious credentials and must have been left less than impressed by the poor phase 2 outcomes. I get the feeling he has taken the bull by the horns, recognised that there is credible, independent research by multiple universities pointing to cannabinoids as an effective anti bacterial. There is serious need, serious $$$ and a quick , low cost path to market in this arena.

    IMO if this company can prove to safely and effectively knock out nasal MRSA I would be amazed if at least 10 bags from here did occur very quickly. After that sky is the limit with human and animal skin infections.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.